PTGER4 and chronic kidney disease: In light of the apparently beneficial effects of EP4 deletion in glomerular cells11, 13 and in light of the pressing need for new treatments, here we hypothesized that EP4 antagonism would attenuate chronic kidney disease (CKD) development, including kidney disease due to diabetes the most common cause of kidney failure16.